Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study

TETRA levels are inversely associated with severity in heart failure with EF>45% and may reflect disease progression.

Authors

Institutions

Publication Details

Journal
Romanian Journal of Internal Medicine
Published
2025-07-26
DOI
https://doi.org/10.2478/rjim-2025-0014
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study

Luminița Pilat, Imola Miklos, Voicu Daşcău, Paula Irina Barata et al.
Romanian Journal of Internal Medicine
Heart Failure Treatment and Management
article

Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study

Luminița Pilat, Imola Miklos, Voicu Daşcău, Paula Irina Barata, Maria Pușchiță, Norberth-Istvan Varga, Călin D. Popa, Paula Alexandra Vulciu, Maria-Daniela Mot
article en

Abstract

TETRA levels are inversely associated with severity in heart failure with EF>45% and may reflect disease progression.

Romanian Journal of Internal MedicineVol. 63(3)
Arad County Clinical Hospital (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO), Vasile Goldis Western University of Arad (RO), Universitatea Nicolae Titulescu din București (RO)
Openalex Percentile: Top 70%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.